Loading clinical trials...
Loading clinical trials...
Combination Chemotherapy (Methotrexate, L-asparaginase, Idarubicin and Dexamethasone) in Patients With Newly Diagnosed Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN)
Conditions
Interventions
Chemotherapy
Locations
2
France
Clinique de L'Europe
Amiens, France
Chu Besancon
Besançon, France
Start Date
May 2, 2019
Primary Completion Date
February 13, 2023
Completion Date
November 1, 2024
Last Updated
February 8, 2024
NCT06006403
NCT04013685
NCT07007052
NCT05645744
NCT03203369
Lead Sponsor
Centre Hospitalier Universitaire de Besancon
Collaborators
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions